For a patient whose Xigduo (metformin/sitagliptin) 5‑1000 mg and 10‑1000 mg formulations are back‑ordered, should I prescribe immediate‑release metformin 500 mg tablets (or extended‑release metformin) along with sitagliptin 1000 mg separately to refill the medication, and what dosing schedule should be used?

Prescribe Separate Dapagliflozin and Metformin ER to Replace Back-Ordered Xigduo

Since Xigduo (dapagliflozin/metformin) 5-1000 mg and 10-1000 mg are back-ordered, prescribe the components separately: dapagliflozin 5 mg or 10 mg once daily (matching the patient's previous dose) plus metformin ER 1000 mg once daily, both taken together in the morning with food. This maintains the same therapeutic regimen without compromising glycemic control or cardiovascular/renal benefits 1.

Practical Prescribing Strategy

Immediate Solution

• Dapagliflozin: Prescribe 5 mg or 10 mg tablet once daily (whichever dose the patient was on)
• Metformin ER: Prescribe 1000 mg once daily
• Timing: Both taken together in the morning with food 1

Why This Works

The FDA label for Xigduo explicitly states that the fixed-dose combination is bioequivalent to separate administration of the individual components 1. Research confirms that sitagliptin/metformin fixed-dose combinations are bioequivalent to co-administration of individual tablets 2, and this principle extends to other metformin combinations. You're not changing the therapy—just the pill count.

Dosing Considerations Based on Kidney Function

Before prescribing, check the patient's most recent eGFR 3, 4:

• eGFR ≥45 mL/min/1.73 m²: Continue metformin 1000 mg ER once daily as before
• eGFR 30-44 mL/min/1.73 m²:
  • Reduce metformin to 500 mg ER once daily (half the dose) 3, 4
  • Continue dapagliflozin at current dose (still provides cardiovascular/renal benefits even with reduced glycemic effect) 3
• eGFR <30 mL/min/1.73 m²: Metformin is contraindicated; discontinue and use dapagliflozin alone 1

Alternative: Metformin ER 500 mg Twice Daily

If metformin ER 1000 mg tablets are also unavailable, prescribe metformin ER 500 mg twice daily (one in morning, one in evening with meals). This provides the same total daily dose but requires twice-daily dosing 3, 4.

Why Not Drop to Plain IR Metformin?

Avoid switching to immediate-release metformin if possible. Extended-release formulations have significantly better GI tolerability—studies show 45% of IR users report GI side effects versus only 24% with ER formulations 5. The ER formulation also reduces pill burden and improves adherence 6, 5, 7. Switching to IR metformin increases the risk of diarrhea, nausea, and treatment discontinuation, which could compromise the patient's diabetes control.

Important Caveats

Monitor for These Issues

1. Vitamin B12 deficiency: Check annually in patients on metformin >4 years 4, 8
2. eGFR monitoring:
   • At least annually if eGFR ≥60 3, 4
   • Every 3-6 months if eGFR 45-59 3, 4
   • More frequently if eGFR 30-44 3, 4
3. Volume status: SGLT2 inhibitors can cause volume depletion; ensure adequate hydration 3

Temporary Discontinuation Scenarios

• Before contrast imaging: Stop metformin 48 hours before if eGFR <60 or patient has liver disease/heart failure; restart when eGFR stable 1
• Before surgery: Withhold both agents ≥3 days before procedures with prolonged fasting 1
• During acute illness: Consider holding SGLT2 inhibitor during critical illness, prolonged fasting, or risk of ketosis 3

Cost and Insurance Considerations

Separate generic dapagliflozin and metformin ER are typically covered similarly to the combination product. If the patient faces insurance issues, document that the combination product is unavailable due to manufacturer back-order—most insurers will approve the separate components under these circumstances.

The key message: This is a straightforward substitution that maintains therapeutic equivalence. The patient gets the same medications at the same doses, just in separate pills instead of one combined tablet.